EOLS · NASDAQ · Drug Manufacturers - Specialty & Generic

Evolus

Sells a cosmetic-only neurotoxin and hyaluronic-acid filler line directly to physicians on a cash-pay basis.

$8.88
After-hours close−0.01 (−0.11%)
At close$8.89(+0.11%)
DateEstimateReportedSurprise
Nov 2026−$0.03
Aug 2026−$0.03$0.01+122.3%
May 2026−$0.14−$0.10+28.6%
Mar 2026$0.06$0.04−26.3%
Nov 2025−$0.19−$0.14+26.3%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Jul 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Oct 2020
Aug 2020
May 2020
Feb 2020
Nov 2019
Aug 2019
Apr 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Feb 2018
Jun 2017
Mar 2017
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 4, 2026−$0.03$77.8M
Aug 5, 2026−$0.03$0.01+122.3%$81.5M$84.1M+3.1%
May 4, 2026−$0.14−$0.10+28.6%$72.5M$73.1M+0.8%
Mar 3, 2026$0.06$0.04−26.3%$89.5M$90.3M+0.9%
Nov 5, 2025−$0.19−$0.14+26.3%$89.6M$69.0M−23.0%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
Aug 5, 2025
May 7, 2025
Mar 4, 2025
Nov 6, 2024
Jul 31, 2024
May 7, 2024
Mar 7, 2024
Nov 7, 2023
Aug 2, 2023
May 9, 2023
Mar 8, 2023
Nov 8, 2022
Aug 2, 2022
May 10, 2022
Mar 3, 2022
Nov 2, 2021
Aug 4, 2021
May 12, 2021
Mar 24, 2021
Oct 29, 2020
Aug 10, 2020
May 11, 2020
Feb 25, 2020
Nov 4, 2019
Aug 12, 2019
Apr 30, 2019
Mar 18, 2019
Nov 5, 2018
Aug 2, 2018
May 10, 2018
Mar 29, 2018
Feb 9, 2018
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016